Try our Advanced Search for more refined results

H. Lundbeck A/S v. United States Patent and Trademark Office (USPTO)

Track this case

Case Number:

1:23-cv-01105

Court:

Virginia Eastern

Nature of Suit:

Patent

Judge:

Patricia Tolliver Giles

Firms

Companies

Sectors & Industries:

  1. July 22, 2024

    USPTO Wins Dismissal Of Danish Co.'s PTSD Drug Lawsuit

    A Virginia federal judge has ruled that the U.S. Patent and Trademark Office appropriately rejected drugmaker Lundbeck's request for three additional months of patent exclusivity for a PTSD drug, saying the agency could dock those days due to the impermissible gray shading of some text in the company's patent application.

  2. February 02, 2024

    USPTO Slams Lundbeck's PTSD Drug Patent Term Suit

    The U.S. Patent and Trademark Office is going for an early win in Virginia federal court where Danish drugmaker H. Lundbeck A/S is seeking to extend the life of a patent for a PTSD drug by three months, calling the case straightforward.

  3. August 22, 2023

    Lundbeck Sues USPTO To Extend Patent Term For PTSD Drug

    Seeking to extend the life of a patent for a PTSD drug by three months, Danish drugmaker H. Lundbeck A/S has sued the U.S. Patent and Trademark Office in Virginia federal court, claiming its "purposeful and deliberate" shortening of the patent term amounts to unjust taking, in violation of the Fifth Amendment.